These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34399400)

  • 1. Intestinal iatrogenic hyperadaptation in patients with short bowel syndrome and Crohn's disease: Is this an indication for mandatory lifelong injections of teduglutide?
    Mazzuoli S; Regano N; Lamacchia S; Silvestri A; Guglielmi FW
    Nutrition; 2021; 91-92():111396. PubMed ID: 34399400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.
    Sato T; Uchino M; Takeuchi J; Fujihira Y; Shimizu K; Yokoyama K; Yagi S; Kaku K; Takashima Y; Ikenouchi M; Kojima K; Kawai M; Nagase K; Kamikozuru K; Yokoyama Y; Takagawa T; Ikeuchi H; Watanabe K; Shinzaki S
    Clin Nutr; 2023 May; 42(5):722-731. PubMed ID: 37001195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Parenteral Nutrition Requirements and BMI in Patients with Parenteral Nutrition-Dependent Short Bowel Syndrome after Stopping Teduglutide-9 Years of Follow-Up.
    Zaczek Z; Jurczak-Kobus P; Panczyk M; Braszczyńska-Sochacka J; Majewska K; Kunecki M; Dąbrowska K; Sobocki J
    Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The indications and results of the use of teduglutide in patients with short bowel.
    El Khatib M; Billiauws L; Joly F
    Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):449-454. PubMed ID: 37421385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failure.
    Pizzoferrato M; Puca P; Ennas S; Cammarota G; Guidi L
    World J Gastroenterol; 2022 Nov; 28(44):6258-6270. PubMed ID: 36504557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epidemiology and Clinical Management of Short Bowel Syndrome and Chronic Intestinal Failure in Crohn's Disease in Italy: An IG-IBD Survey.
    Pessarelli T; Topa M; Sorge A; Nandi N; Pugliese D; Macaluso FS; Orlando A; Saibeni S; Costantino A; Stalla F; Zadro V; Scaramella L; Vecchi M; Caprioli F; Elli L
    Nutrients; 2024 Sep; 16(19):. PubMed ID: 39408277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-Bowel Adaptation: A Case of Morphological Changes Induced by Teduglutide in Short-Bowel Syndrome With Intestinal Failure.
    Mouillot T; Boehm V; Treton X; Ferrandi E; Kapel N; Cazals-Hatem D; Joly F
    JPEN J Parenter Enteral Nutr; 2020 Jul; 44(5):940-943. PubMed ID: 32187383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
    Seidner DL; Fujioka K; Boullata JI; Iyer K; Lee HM; Ziegler TR
    Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teduglutide-induced acute gastric mucosal necrosis in short bowel syndrome with hepatorenal failure: Case report.
    Takahashi T; Maejima T; Miyazaki D; Fukahori S; Hagiwara M
    Int J Surg Case Rep; 2024 Apr; 117():109524. PubMed ID: 38493615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition.
    Iturrino J; Camilleri M; Acosta A; O'Neill J; Burton D; Edakkanambeth Varayil J; Carlson PJ; Zinsmeister AR; Hurt R
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1089-1095. PubMed ID: 26223941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Outcomes Associated With Teduglutide Use in Patients With Both Short Bowel Syndrome and Crohn's Disease.
    Siu RK; Karime C; Hashash JG; Kinnucan J; Picco MF; Farraye FA
    Crohns Colitis 360; 2024 Jan; 6(1):otae007. PubMed ID: 38352117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short-Bowel Syndrome: A Review of Recent Literature.
    Pironi L
    JPEN J Parenter Enteral Nutr; 2020 Aug; 44(6):968-978. PubMed ID: 31802516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.
    Yazbeck R
    Curr Opin Mol Ther; 2010 Dec; 12(6):798-809. PubMed ID: 21154171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the Intestinotrophic Effects of 2 Glucagon-Like Peptide-2 Analogues in the Treatment of Short-Bowel Syndrome in Neonatal Piglets.
    Pauline ML; Nation PN; Wizzard PR; Hinchliffe T; Wu T; Dimitriadou V; Turner JM; Wales PW
    JPEN J Parenter Enteral Nutr; 2021 Mar; 45(3):538-545. PubMed ID: 32437048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
    Kochar B; Long MD; Shelton E; Young L; Farraye FA; Yajnik V; Herfarth H
    J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging as predictor of clinical response to teduglutide in adult patients with short bowel syndrome with chronic intestinal failure.
    Martin A; Boehm V; Zappa M; Billiauws L; Bonvalet F; Nuzzo A; Vilgrain V; Joly F; Ronot M
    Am J Clin Nutr; 2021 May; 113(5):1343-1350. PubMed ID: 33675349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry.
    Gondolesi GE; Pape UF; Mason JB; Allard JP; Pironi L; Casas MNV; Schwartz LK; Joly F; Gabriel A; Sabrdaran S; Zhang P; Kohl-Sobania M; Huang YW; Jeppesen PB
    Nutrients; 2024 Aug; 16(15):. PubMed ID: 39125394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
    Greif S; Maasberg S; Wehkamp J; Fusco S; Zopf Y; Herrmann HJ; Lamprecht G; Jacob T; Schiefke I; von Websky MW; Büttner J; Blüthner E; Tacke F; Pape UF
    Clin Nutr ESPEN; 2022 Oct; 51():222-230. PubMed ID: 36184208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure.
    Wales PW; Hill S; Robinson I; Raphael BP; Matthews C; Cohran V; Carter B; Venick R; Kocoshis S
    J Pediatr Gastroenterol Nutr; 2024 Aug; 79(2):290-300. PubMed ID: 38873891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
    Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
    Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.